Development and validation of cardiovascular risk scores for haemodialysis patients
- 1 August 2016
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 216, 68-77
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Clinical Practices and Outcomes in Elderly Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Malnutrition-Inflammation Modifies the Relationship of Cholesterol with Cardiovascular DiseaseJournal of the American Society of Nephrology, 2010
- Modeling the 4D StudyClinical Journal of the American Society of Nephrology, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Greater Epoetin alfa (EPO) doses and short‐term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dLPharmacoepidemiology and Drug Safety, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney diseaseKidney International, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004